Is GSGTF or JEPQ a better dividend investment in 2026?

GSGTF currently yields 1052.08% with a 5% 5-year dividend growth rate. JEPQ yields 11.10% with 5% growth. The better choice depends on your goal: GSGTF offers higher current income.

What is the dividend yield difference between GSGTF and JEPQ?

GSGTF has a forward dividend yield of 1052.08% ($2.00/share annually). JEPQ yields 11.10% ($6.16/share annually). The yield gap is 1040.98 percentage points.

Home › Compare › GSGTF vs JEPQ

GSGTF vs JEPQ: Dividend Comparison 2026

GSGTF yields 1052.08% · JEPQ yields 11.10%● Live data

vsPost on X →

After 10 years · $10,000 invested · DRIP enabled

🏆 GSGTF wins by $29376466.50M in total portfolio value

INVESTMENT

TIME HORIZON10 years

GSGTF

● Live price

1052.08%

Share price

$0.19

Annual div

$2.00

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$29376466.55M

Annual income

$24,748,961,707,406.69

Full GSGTF calculator →

JEPQ

JPMorgan Nasdaq Equity Premium Income ETF

● Live price

11.10%

Share price

$55.52

Annual div

$6.16

5Y div CAGR

Payout ratio

50%

After 10 yrs · $10,000 · DRIP

Portfolio value

$44.8K

Annual income

$2,152.59

Full JEPQ calculator →

Portfolio growth — GSGTF vs JEPQ

📍 GSGTF pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis Period	GSGTF	JEPQ
2008–2009 GFC	— No data	— No data
2020 Q1–Q2 COVID	— No data	— No data
2022 Q4 Rate Hike	— No data	— No data

Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.

📅

Dividend Calendar Overlap

Combined, GSGTF + JEPQ cover 0 of 12 months — good coverage

Jan

—

Feb

—

Mar

—

Apr

—

May

—

Jun

—

Jul

—

Aug

—

Sep

—

Oct

—

Nov

—

Dec

—

GSGTF pays

JEPQ pays

Both pay

Neither

💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

GSGTF

Annual income on $10K today (after 15% tax)

$89,426.62/yr

After 10yr DRIP, annual income (after tax)

$21,036,617,451,295.69/yr

JEPQ

Annual income on $10K today (after 15% tax)

$943.83/yr

After 10yr DRIP, annual income (after tax)

$1,829.70/yr

At 15% tax rate, GSGTF beats the other by $21,036,617,449,465.98/year in after-tax income after 10 years on $10,000

⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of GSGTF + JEPQ for your $10,000?

GSGTF: 50%JEPQ: 50%

100% JEPQ50/50100% GSGTF

Portfolio after 10yr

$14688233.30M

Annual income

$12,374,480,854,779.64/yr

Blended yield

84.25%

🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

GSGTF buys

JEPQ buys

No recent congressional trades found for GSGTF or JEPQ in the last 90 days.

STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →

MetricGSGTFJEPQ

Forward yield	1052.08% ✓	11.10%
Annual dividend / share	$2.00	$6.16 ✓
Payout ratio	50%	50%
1-year div growth	0%	0%
5-year div CAGR	0%	0%
Portfolio after 10y	$29376466.55M ✓	$44.8K
Annual income after 10y	$24,748,961,707,406.69 ✓	$2,152.59
Total dividends collected	$29025351.72M ✓	$16.3K
Payment frequency	quarterly	monthly
Sector	Stock	ETF

Year-by-year: GSGTF vs JEPQ ($10,000, DRIP)

Year	GSGTF Portfolio	GSGTF Income/yr	JEPQ Portfolio	JEPQ Income/yr	Gap
1← crossover	$115,908	$105,207.79	$11,930	$1,110.39	+$104.0K → GSGTF
2	$1,263,685	$1,139,663.68	$14,133	$1,224.34	+$1.25M → GSGTF
3	$12,964,467	$11,612,324.37	$16,632	$1,340.46	+$12.95M → GSGTF
4	$125,211,982	$111,340,001.64	$19,454	$1,457.97	+$125.19M → GSGTF
5	$1,138,959,685	$1,004,982,865.01	$22,626	$1,576.08	+$1138.94M → GSGTF
6	$9,762,216,739	$8,543,529,875.74	$26,175	$1,694.09	+$9762.19M → GSGTF
7	$78,882,996,544	$68,437,424,632.64	$30,133	$1,811.32	+$78882.97M → GSGTF
8	$601,231,379,017	$516,826,572,714.96	$34,531	$1,927.17	+$601231.34M → GSGTF
9	$4,324,770,879,470	$3,681,453,303,922.24	$39,403	$2,041.08	+$4324770.84M → GSGTF
10	$29,376,466,548,439	$24,748,961,707,406.69	$44,787	$2,152.59	+$29376466.50M → GSGTF

GSGTF vs JEPQ: Complete Analysis 2026

GSGTF — Stock

GenSight Biologics S.A., a clinical-stage biotechnology company, engages in the discovery, development, and commercialization of therapies for mitochondrial and neurodegenerative diseases of the eye and central nervous system. The company develops its products through gene therapy-based mitochondrial targeting sequence and optogenetics technology platforms. Its lead product candidates include LUMEVOQ (GS010), a recombinant AAV2-based gene therapy, which is in Phase III clinical trials for the treatment of leber hereditary optic neuropathy caused by a mutated ND4 gene; and GS030, which is in Phase I/II clinical trial for the treatment of retinitis pigmentosa, as well as in preclinical stage to treat dry age-related macular degeneration. The company also develops products that are in preclinical stage targeting ophthalmic and neurodegenerative diseases. GenSight Biologics S.A. was incorporated in 2012 and is headquartered in Paris, France.

Full GSGTF Calculator →

JEPQ — ETF

The fund seeks to achieve this objective by (1) creating an actively managed portfolio of equity securities comprised significantly of those included in the fund’s primary benchmark, the Nasdaq-100 Index (the Benchmark), and (2) through equity-linked notes (ELNs), selling call options with exposure to the Benchmark. It is non-diversified.

Full JEPQ Calculator →

📬

Get this GSGTF vs JEPQ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

GSGTF vs SCHD GSGTF vs JEPI GSGTF vs O GSGTF vs KO GSGTF vs MAIN GSGTF vs XYLD GSGTF vs QYLD GSGTF vs VYM

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.